Rennova Health, Inc. RNVA
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | 112.11% | -103.04% | -158.75% | -154.71% |
| Total Depreciation and Amortization | -- | -33.95% | -22.34% | -27.07% | -41.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 73.51% | 93.28% | 95.12% | 98.40% |
| Change in Net Operating Assets | -- | 1,074.14% | 305.73% | -19.85% | -96.11% |
| Cash from Operations | -- | 133.38% | 123.18% | 97.55% | 51.74% |
| Capital Expenditure | -- | -580.09% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 6.04% | -110.54% | -132.28% | -357.24% |
| Cash from Investing | -- | -28.97% | -161.52% | -141.74% | -895.80% |
| Total Debt Issued | -- | 0.06% | -14.29% | -27.40% | -77.24% |
| Total Debt Repaid | -- | 13.44% | 10.79% | -8.38% | -168.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -100.00% | -95.00% | -83.33% | 10.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -125.83% | -161.88% | -187.03% | -53.70% |
| Cash from Financing | -- | -114.59% | -106.48% | -91.00% | -48.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 271.11% | 368.35% | -132.18% | -388.22% |